| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/29/2010 | EP2231205A2 Colloidal collagen burn wound dressing produced from jellyfish |
| 09/29/2010 | EP2231181A1 New vaccine for the treatment of mycobacterium related disorders |
| 09/29/2010 | EP2231178A1 Methods for inhibiting scarring |
| 09/29/2010 | EP2231177A1 Trophic factor for the treatment of retinal degenerative diseases |
| 09/29/2010 | EP2231176A2 Treatment and prevention of hiv infection |
| 09/29/2010 | EP2231175A2 Protein formulations and methods of making same |
| 09/29/2010 | EP2231171A2 Compositions and methods for increasing iron absorption |
| 09/29/2010 | EP2231140A1 Sigma ligands and ikk / nf - kb inhibitors for medical treatment |
| 09/29/2010 | EP2231120A1 Solid lipid microcapsules containing growth hormone in the inner solid core |
| 09/29/2010 | EP2231107A1 Use of a neurotoxic component of a clostridium botulinum toxin complex to reduce or prevent side effects |
| 09/29/2010 | EP2231106A2 Cosmetic use of plakoglobin-type proteins |
| 09/29/2010 | EP1692159B1 Tgf-beta1 binding and supported peptides |
| 09/29/2010 | EP1608411B1 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure. |
| 09/29/2010 | EP1572952B1 Novel polynucleotide and polypeptide sequences and uses thereof |
| 09/29/2010 | EP1569953B1 Peptide gap junction modulators |
| 09/29/2010 | EP1450847B1 APO2 ligand/ TRAIL formulations and uses thereof |
| 09/29/2010 | EP1095274B1 Trifunctional reagent for conjugation to a biomolecule |
| 09/29/2010 | CN1935254B Method for neuregulin treating cardio vascular disease, and composition |
| 09/29/2010 | CN1893919B Endoparasiticidal agents for topical application |
| 09/29/2010 | CN1864744B Pharmaceutical preparation containing urate oxidase |
| 09/29/2010 | CN1860364B Fluorescently tagged ligands |
| 09/29/2010 | CN1859943B System for controlling concentration of glucose in a patient |
| 09/29/2010 | CN101849019A Detection of micro-organisms based on their NAD-dependent DNA ligase activity |
| 09/29/2010 | CN101848934A Neuroprotection using NAP-like and SAL-like peptide mimetics |
| 09/29/2010 | CN101848932A Peptide having hypotensive activity |
| 09/29/2010 | CN101848926A Peptide capable of binding to immunoglobulin |
| 09/29/2010 | CN101848735A Novel neurturin conjugates for pharmaceutical use |
| 09/29/2010 | CN101848728A Pharmaceutical compositions containing the enzyme cyprosin, an aspartic peptidase from cynara cardunculus and its inclusion in antitumour formulations |
| 09/29/2010 | CN101848727A Apolactoferrin compositions and methods of the use thereof for treating viral hepatitis c |
| 09/29/2010 | CN101848726A Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury |
| 09/29/2010 | CN101848725A 组合物 The composition |
| 09/29/2010 | CN101848724A Use of TRL-2 antagonists for treatment of reperfusion injury and tissue damage |
| 09/29/2010 | CN101848723A Bacteriocin inducer peptides |
| 09/29/2010 | CN101848722A Novel peptide amphiphiles having improved solubility and methods of using same |
| 09/29/2010 | CN101848721A Active agents, compositions, and methods for inhibiting and reversing platelet function |
| 09/29/2010 | CN101848720A 糖尿病治疗剂 Therapeutic agents for diabetes |
| 09/29/2010 | CN101848719A Influenza inhibiting compositions and methods |
| 09/29/2010 | CN101848702A Micellar nanoparticles comprising botulinum toxin |
| 09/29/2010 | CN101845446A Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
| 09/29/2010 | CN101845442A Method for preparing human interleukin 28A by silkworm bioreactor and pharmaceutical application thereof |
| 09/29/2010 | CN101845099A Long-acting analgesic peptide and application thereof |
| 09/29/2010 | CN101845091A Metastin derivatives and use thereof |
| 09/29/2010 | CN101845082A Porcine hemagglutinating encepha lomyelitis virus binding protein and preparation method and use thereof |
| 09/29/2010 | CN101845081A Cyclic hexapeptide antibacterial compound |
| 09/29/2010 | CN101845079A Hexapeptide or derivative thereof and medical application thereof |
| 09/29/2010 | CN101843904A Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 09/29/2010 | CN101843898A Application of marine collagen peptide in preparing drugs, health-care foods or foods for tumor prevention and inhibition |
| 09/29/2010 | CN101843897A Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
| 09/29/2010 | CN101843896A Recombinant human interferon alpha 2b injection with high concentration and low filling quantity |
| 09/29/2010 | CN101843895A Cytokine receptor ZCYTOR17 multimers |
| 09/29/2010 | CN101843894A Application of pumpkin protein to preparation of medicament for treating lung cancer |
| 09/29/2010 | CN101843893A Application of cyclosporin A in preparing anti-rotavirus medicaments |
| 09/29/2010 | CN101843892A Medicament composition comprising Enalapril quick-releasing part and felodipine slow-releasing part |
| 09/29/2010 | CN101843609A Medicament for use in connection with cartilage impairment |
| 09/29/2010 | CN101843595A Formula of oral mucosa absorbing dosage form of medicines of polypeptides and proteins, and preparation method and application thereof |
| 09/29/2010 | CN101843585A Method for preparing whole peptidoglycan magnetic liposome |
| 09/29/2010 | CN101843580A Preparation method of pidotimod injection preparation |
| 09/29/2010 | CN101450035B Double sustained release biological agent for tumor local ablation therapy |
| 09/29/2010 | CN101318992B Complete-basic amino acid oligopeptide, copper complex, synthesis method, self-assembly and application thereof |
| 09/29/2010 | CN101177453B Recombined chimeric antibody against human tumor necrosis factor alpha |
| 09/29/2010 | CN101152557B Preparation of aqueous extract and zymolyte of woodlousedry powder, and application of the same in medicine |
| 09/29/2010 | CN101147800B Casein phosphopeptide cyclodextrin inclusion compound without bitter and its preparation method |
| 09/29/2010 | CN101085809B Synthetic and preparing technique for Batifeiban and analogue |
| 09/29/2010 | CN101062946B High-active liver regeneration reinforced factor and usage thereof |
| 09/29/2010 | CN101054414B Method of extracting and preparing deer DGF |
| 09/29/2010 | CN101041687B PGE2 differential combined phage lambda ring seven peptide and sifting method and usage of synthesized peptide |
| 09/28/2010 | USRE41783 Pyrrolo[2,3-D]pyrimidine compounds |
| 09/28/2010 | US7803982 Recombinant rodent comprising mutant g protein coupled receptor for use in identifying modulators of taste; artificial sweetners; flavoring |
| 09/28/2010 | US7803944 Viral polymerase inhibitors |
| 09/28/2010 | US7803930 Antisense modulation of apolipoprotein B-expression |
| 09/28/2010 | US7803926 Immunology; immunogens; cloning; host cell biosynthesis |
| 09/28/2010 | US7803923 Growth differentiation factor-8 binding agents for treatment of metabolic, nervous system, muscular, bone , urogenital and inflammatory disorders; for treating muscle-wasting disorders and metabolic disorders including diabetes and obesity |
| 09/28/2010 | US7803918 gene delivery vehicle comprising the isolated and/or recombinant nucleic acid sequence; methods for typing the virus in various samples and diagnosing of disease |
| 09/28/2010 | US7803911 preparing a stable dried composition of blood factor product containing a stabilizing amount of trehalose in the absence of a stabilizing amount of albumin |
| 09/28/2010 | US7803909 Truncated tyrosine kinase for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 09/28/2010 | US7803907 Polypeptides comprising monomer domains that bind to c-MET; polynucleotide encoding the polypeptide; cancer |
| 09/28/2010 | US7803906 Nucleotide sequences and polypeptides; nucleic acids; induce gene expression |
| 09/28/2010 | US7803905 Comprises genetically engineered matrix proteins immobilized on solid support for implantation, repair and treatment of bone disorders |
| 09/28/2010 | US7803901 for inducing a natriuretic (excretion of an excessively large amount of sodium in the urine) or diuretic activity within a mammal |
| 09/28/2010 | US7803791 biological conjugate drug comprising enzyme inhibitor antibiotics and protein, for the treatment and/or prophylaxis of bacterial inflammatory processes, solid tumor; norfloxacin with albumin; antiinflammatory agents, antitumor agents |
| 09/28/2010 | US7803785 gemcitabine derivative containing 3* hydroxy-4*-hydroxymethyl substitution in furan ring and pyrimidine ring having substitution HNC(=O)CH3; treat or prevent diseases or disorders such as cancer or viral infections |
| 09/28/2010 | US7803780 gene therapy of transferring the CD9 gene for suppressing cardiac hypertrophy or cardiac tachycardia in a patient having a heart disease; viral or non-viral expression vector containing a sequence encoding a CD9 protein |
| 09/28/2010 | US7803777 conjugates of polyoxyethylene glycol with diverse therapeutic agents, e.g., peptides, lipids, glycolipids and small molecules; utility in biotechnology and medicine |
| 09/28/2010 | US7803776 Combined use of enzyme inhibitors and of pharmaceutical compositions thereof |
| 09/28/2010 | US7803775 Kit comprising inhibitory peptide for use in reducing side effects of drug cessation |
| 09/28/2010 | US7803774 retro-inverso isomers of beta-amyloid peptides, used for diagnosis and treatment of amyloidogenic diseases such as Alzheimer's disease |
| 09/28/2010 | US7803773 Subcutaneously implanting a device containing octreotide or acetate salt and hydroxpropylcellulose encased in a hydrophilic addition copolymer., e.g., hydroxyethyl- hydroxypropyl methacrylate; delivers octreotide over 6 months at a controlled rate to avoid the suffering of multiple periodic injections. |
| 09/28/2010 | US7803772 Administering a polypeptide having at least one of anti-angiogenic, tumor-suppressive, or anti-migratory activity, but does not have stimulation of cell proliferation activity |
| 09/28/2010 | US7803771 cell carrier particle comprising 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide crosslinked recombinantly produced gelatin polypeptides having at least two outer lysine residues which are separated by at least 25 percent of the total number of amino acids; tissue augmentation or cosmetic surgery |
| 09/28/2010 | US7803770 administering storage-stable composition containing a parathyroid hormone-related protein; for parenteral administration |
| 09/28/2010 | US7803769 wherein the C-terminal carboxylic acid moiety is replaced; for treating an autoimmune disorder and preventing or mitigating a relapse of a symptom of multiple sclerosis, or treatment of type 1 diabetes, psoriasis, inflammatory bowel disease, Crohn's Disease, ulcerative colitis |
| 09/28/2010 | US7803768 administering peptide compound wherein compound is growth hormone-releasing peptide-2 (GHRP-2) or a peptide having an amino acid sequence wherein 3rd amino acid residue from an amino terminus is a modified residue wherein a side chain is acylated by fatty acid; ghrelin is especially desirable |
| 09/28/2010 | US7803766 administering gastrin/(cholecystokinin (CCK) receptor ligand and a factor for complementing gastrin for islet neogenesis therapy; sustained release; for expanding a functional beta cell mass of pancreatic islet transplants; reduces amount of stem cells necessary for treatment; long-acting action |
| 09/28/2010 | US7803765 production and of nucleic acid fragment libraries that express highly diverse peptides, polypeptides or protein domains and, in particular, nucleic acid fragment libraries wherein the nucleic acid fragments are derived from two or more prokaryote genomes or compact eukaryote genomes |
| 09/28/2010 | US7803764 Crossing blood-brain barrier; central nervous system disorders; psychological disorders; behavioral disorders |
| 09/28/2010 | US7803763 Anion/cationic exchanging and chromatography; crystallization |
| 09/28/2010 | US7803762 Anticoagulants comprising one or more stabilizers; without pretreatment of drug prior to patient administration; acidity; stable storage at 25 degrees C. for 1 month |
| 09/28/2010 | US7803761 Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders |
| 09/28/2010 | US7803760 Methods of inducing ovulation |
| 09/28/2010 | US7803759 S-nitrosoprotein preparation and production method therefor |